NICE guidelines for management of chest pain: Difference between revisions
Line 101: | Line 101: | ||
==NICE guidelines for the management of patients with stable chest pain <ref name="pmid22420013">{{cite journal |author= |title= |journal=[[]] |volume= |issue= |pages= |year= |pmid=22420013 |doi= |url= |accessdate=2012-05-08}}</ref>== | ==NICE guidelines for the management of patients with stable chest pain <ref name="pmid22420013">{{cite journal |author= |title= |journal=[[]] |volume= |issue= |pages= |year= |pmid=22420013 |doi= |url= |accessdate=2012-05-08}}</ref>== | ||
*'''[[NICE guidelines for the management of patients with stable chest pain]]''' | *'''[[NICE guidelines for the management of patients with stable chest pain]]''' | ||
[[National Institute for Health and Clinical Excellence]] ([[NICE]]) has dramatically changed its guideline on approach to stable [[chest pain]] aiming to find a more cost-effective strategy including NO use of pretest probability risk scores or NO use of functional tests, such as [[stress echocardiography]], as a first-line investigation in [[patients]] with new-onset stable [[chest pain]]. The suggestion is to use CT coronary angiography in the majority of [[patients]]. However, the recommendation of [[European | |||
Society of Echocardiography]] ([[ESC]]—2013) is functional tests as the initial investigation. | |||
Revision as of 10:00, 14 January 2022
Chest pain Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
NICE guidelines for management of chest pain On the Web |
to Hospitals Treating NICE guidelines for management of chest pain |
Risk calculators and risk factors for NICE guidelines for management of chest pain |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Priyamvada Singh, M.B.B.S. [3]
Overview
National Institute for Health and Clinical Excellence (NICE) has dramatically changed its guideline on approach to stable chest pain aiming to find a more cost-effective strategy including NO use of pretest probability risk scores or NO use of functional tests, such as stress echocardiography, as a first-line investigation in patients with new-onset stable chest pain. The suggestion is to use CT coronary angiography in the majority of patients. However, the recommendation of [[European Society of Echocardiography]] (ESC—2013) is functional tests as the initial investigation.
NICE Guidelines for the Management of Patients with Chest Pain (DO NOT EDIT)[1]
“ |
Key Priorities for Implementation in Patients with Acute Chest Pain
Key Priorities for Implementation in Patients with Stable Chest Pain
Providing Information for People with Chest Pain
|
” |
NICE Guidelines for the Management of Patients with Acute Chest Pain [1]
Investigation and diagnosis of acute chest pain in hospital
Assessment of acute chest pain in hospital
| |||||||||||||||||||||||||||||||||||||||||||||||||
Normal resting ECG or non-diagnostic | ECG changes consistent with NSTEMI | ECG changes consistent with STEMI | |||||||||||||||||||||||||||||||||||||||||||||||
Low risk patient with undetectable hs-troponin level: Reassurance, discharge | Consider ACS by clinical judgment even in the presence of normal ECG
| NSTEMI, ACS Guideline follow-up | STEMI Guideline follow-up | ||||||||||||||||||||||||||||||||||||||||||||||
hs-troponin concentration on arrival and at 3 hours bellow the cut-off measurement: Low risk patient, discharge | hs-troponin concentration on arrival and at 3 hours higher than cut-off measurement | Diagnostic criteria for MI | |||||||||||||||||||||||||||||||||||||||||||||||
Yes: | NO:
| ||||||||||||||||||||||||||||||||||||||||||||||||
The above algorithm adopted from 2016 NICE Guideline |
---|
NICE guidelines for the management of patients with stable chest pain [1]
National Institute for Health and Clinical Excellence (NICE) has dramatically changed its guideline on approach to stable chest pain aiming to find a more cost-effective strategy including NO use of pretest probability risk scores or NO use of functional tests, such as stress echocardiography, as a first-line investigation in patients with new-onset stable chest pain. The suggestion is to use CT coronary angiography in the majority of patients. However, the recommendation of [[European Society of Echocardiography]] (ESC—2013) is functional tests as the initial investigation.
Assessment and detailed history
| |||||||||||||||||||||||||
Non anginal aspect of chest pain without cardiac risk factors or clinical suspicious | Typical or atypical anginal in clinical assessment | ||||||||||||||||||||||||
Indentify other causes of chest pain
| Consider resting ECG
| ||||||||||||||||||||||||
The above algorithm adopted from 2016 NICE Guideline |
---|
Consider 64 slice (or obove) Coronary CT Angiography in the presence of:
| |||||||||||||||||||
Consider non-invasive functional imaging in the presence of:
| Consider stable angina in the presence of obstructive CAD on coronary CT angiography or reversible ischemia on functional imaging study
| ||||||||||||||||||
Stable chest pain: ❑ Typical stable angina symptoms:
| |||||||||||||||||||||||
Stable angina is unlikely if chest pain is: ❑ Not related to the activity | |||||||||||||||||||||||
ECG changes associated with CAD: ❑ LBBB
| |||||||||||||||||||||||
Non-invasive functional imaging study for evaluation of myocardial ischemia: ❑Myocardial perfusion scintigraphy with single photon emission CT ( with adenosin, dipyridamole, dobutamine ❑ Stress echocardiography (with exercise or dobutamine ❑First pass contrast enhanced MR perfusion with adenosine or dipyridamole ❑ MR imaging with exercise or dobutamine | |||||||||||||||||||||||
Definition of significant CAD: ❑Coronary CT angiography:
❑ Factors associated with intensifying ischemia in the lesions less than 50%
❑ Factors associated reduced ischemia in significant lesion ≥70 %:
| |||||||||||||||||||||||
The above algorithm adopted from 2016 NICE Guideline |
---|